Ferrari, C.; Pisani, A.R.; Masi, T.; Santo, G.; Mammucci, P.; Rubini, D.; Sardaro, A.; Rubini, G.
Lesion-to-Liver SUVmax Ratio to Improve the Prognostic Value of the End of Treatment PET/CT in Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 5541.
https://doi.org/10.3390/jcm11195541
AMA Style
Ferrari C, Pisani AR, Masi T, Santo G, Mammucci P, Rubini D, Sardaro A, Rubini G.
Lesion-to-Liver SUVmax Ratio to Improve the Prognostic Value of the End of Treatment PET/CT in Diffuse Large B-Cell Lymphoma. Journal of Clinical Medicine. 2022; 11(19):5541.
https://doi.org/10.3390/jcm11195541
Chicago/Turabian Style
Ferrari, Cristina, Antonio Rosario Pisani, Tamara Masi, Giulia Santo, Paolo Mammucci, Dino Rubini, Angela Sardaro, and Giuseppe Rubini.
2022. "Lesion-to-Liver SUVmax Ratio to Improve the Prognostic Value of the End of Treatment PET/CT in Diffuse Large B-Cell Lymphoma" Journal of Clinical Medicine 11, no. 19: 5541.
https://doi.org/10.3390/jcm11195541
APA Style
Ferrari, C., Pisani, A. R., Masi, T., Santo, G., Mammucci, P., Rubini, D., Sardaro, A., & Rubini, G.
(2022). Lesion-to-Liver SUVmax Ratio to Improve the Prognostic Value of the End of Treatment PET/CT in Diffuse Large B-Cell Lymphoma. Journal of Clinical Medicine, 11(19), 5541.
https://doi.org/10.3390/jcm11195541
